Electrolyte Blood Press.  2006 Nov;4(2):83-86. 10.5049/EBP.2006.4.2.83.

A Case of Primary Aldosteronism with End Stage Renal Disease

• Na HH
• Park KJ
• Kim SY
• Koh HI

• KMID: 2052276
• DOI: http://doi.org/10.5049/EBP.2006.4.2.83

Abstract

A 52-year-old woman was referred to our hospital due to chronic renal failure with a 10-year history of hypertension. We found polycystic kidney disease, pulmonary tuberculosis and an aldosterone-producing adrenocortical mass. At this time, her serum potassium level and blood pressure were within the normal range. She refused hemodialysis and then was hospitalized because of uremic encephalopathy. On admission, her serum potassium level was normal without treatment and plasma aldosterone concentration highly elevated. She received hemodialysis, and thereafter hypokalemia developed. We then administered spironolactone, whereupon serum potassium level returned to the normal range. In this case, we thought that normokalemia was balanced hypokalemia of primary aldosteronism with hyperkalemia of chronic renal failure, and that hypokalemia developed after hemodialysis was due to an imbalanced primary aldosteronism with end stage renal disease.

MeSH Terms

Aldosterone
Blood Pressure
Female
Humans
Hyperaldosteronism*
Hyperkalemia
Hypertension
Hypokalemia
Kidney Failure, Chronic*
Middle Aged
Plasma
Polycystic Kidney Diseases
Potassium
Reference Values
Renal Dialysis
Spironolactone
Tuberculosis, Pulmonary
Aldosterone
Potassium
Spironolactone

Figure

• 

  Fig. 1 Abdominopelvic computed tomography with enhancement. An inhomogenous 4.4×2.8 cm sized mass lesion is noted in right adrenal gland.

Reference

1. Conn JW. Primary aldosteronim: A new clinical syndrome. J Lab Clin Med. 1955; 45:6–17.

2. Bravo E, Tarazi R, Dustan H, Fouad F, Textor S, Gifford R, et al. The changing clinical spectrum of primary hyperaldosteronism. Am J Med. 1983; 74:641–651. PMID: 6340491.

3. Matsuda K, Shimamoto K, Ura N, Ogata H, Shizukuda Y, Iwakura M, Nozawa A, Kikuchi K, Iimura O. A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatment. Endocrinol Jpn. 1989; 36:681–686. PMID: 2620664.

4. Nakada T, Kimura M. Primary aldosteronism associated with chronic renal failure : Report of a case. Int Urol Ntphrol. 1983; 16:165–173.

5. Koshiyama H, Fujisawa T, Kuwamura N, Nakamura Y, Kanamori H, Oida E, Hara A, Suzuki T, Sasano H. A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure. Endocrine. 2003; 21:221–226. PMID: 14515005.

6. Sung JR, Song KI, Kim JH, Cha MK, Lee EY, Park MS, Han DC, Jin SY, Hwang SD, Moon C, Lee HB. A case of primary aldosteronism, nephrotic syndrome and chronic renal failure: a diagnostic dilemma. Korean J Nephrol. 1997; 16:162–166.

7. Kim YS, Choi HY, Kim HJ, Kim DK, Jung IH, Lee TH, Yoon SY, Choi KH, Kang SW, Lee HY, Han DS, Chung HJ. Primary aldosteronism complicated with chronic renal failure. Korean J Nephrol. 2003; 22:156–160.

8. Park DJ, Yang JI, Choi YM, Kang MJ, Kim HJ, Lee SS, Lee JD, Chang SH, Chung SI, Kwon SI. Autosomal dominant polycystic kidney disease complicated by aldosterone-producing adrenal adenoma. Korean J Nephrol. 1998; 17:968–972.

9. Zimmerman RS, Edwards BS, Schwab TR, Heublein DM, Burnet JC. Atrial natriuretic peptide during mineralocorticoid escape in the human. J Clin Endocrinol Metab. 1987; 64:624–627. PMID: 2950127.

10. Vantyghem MC, Ronci N, Provost F, Ghulam A, Lefebvre J, Jeunemaitre X, Tabarin A. Aldosterone-producing adenoma without hypertension : a report of two cases. Eur J Endocrinol. 1999; 141:279–285. PMID: 10474126.

11. Saruta IT, Kondo K, Ozawa Y, Hata J, Shimizu K. Renin and juxtaglomerular apparatus in a patient with primary aldosteronism complicated by chronic renal failure. South Med J. 1976; 69:951–952. PMID: 941067.

12. Oelkers W, Diederich S, Bähr V. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage. J Clin Endocrinol Metab. 2000; 85:3266–3270. PMID: 10999820.